Division of Fresenius SE & Co. KGaA
Latest From Fenwal Inc.
The medtech M&A deal count soared in October with a total of 30 deals announced and closed in the month. It was an especially busy month for the orthopedics sector, with a number of high profile deals inked.
The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.
- Medical Devices
- Therapeutic Areas
- Transfusion Therapies
- North America
- Parent & Subsidiaries
- Fresenius SE & Co. KGaA
- Senior Management
Ron K Labrum, Pres. & CEO
Michael L Johnson, SVP & CFO
Dean A Gregory , SVP, Commercial Operations
- Contact Info
Phone: (800) 333-6925
Three Corporate Dr.
Lake Zurich, IL 60047
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.